Source:http://linkedlifedata.com/resource/pubmed/id/12858187
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006765,
umls-concept:C0009491,
umls-concept:C0017337,
umls-concept:C0026336,
umls-concept:C0033147,
umls-concept:C0042196,
umls-concept:C0086022,
umls-concept:C0205314,
umls-concept:C0206679,
umls-concept:C0442111,
umls-concept:C0442335,
umls-concept:C0679622,
umls-concept:C1280500,
umls-concept:C1527148,
umls-concept:C1579762,
umls-concept:C1705099,
umls-concept:C1705187,
umls-concept:C1709630
|
pubmed:issue |
15
|
pubmed:dateCreated |
2003-7-14
|
pubmed:abstractText |
The owl monkey (Aotus trivirgatus) has served as the standard non-human primate model of herpes simplex virus-1 (HSV-1) infection because it is highly susceptible to HSV-1 encephalitis. Owl monkeys, however, are expensive, difficult to obtain, and difficult to maintain in captivity, thus greatly hampering the efficiency of preclinical gene therapy trials for brain tumors using HSV-1-based vectors. We have therefore compared the susceptibility of the common marmoset (Callithrix jacchus) with the owl monkey in a model of intracerebral inoculation of wildtype HSV-1 F-strain at increasing titers. The common marmosets consistently succumbed earlier to viral encephalitis than the owl monkeys. The histological evaluation of the common marmoset revealed extensive HSV-1 infection with a concomitant yet less marked inflammatory response compared to the owl monkeys. PCR for HSV-1 demonstrated a similar extra-CNS shedding route in both experimental models. Our findings show that the common marmoset is at least as susceptible to intracerebral HSV-infection as the owl monkey and that it can therefore serve as a valid and reliable experimental model for the important preclinical safety tests of HSV-based therapeutic viral vector constructs in the brain.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0969-7128
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1225-33
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12858187-Animals,
pubmed-meshheading:12858187-Brain,
pubmed-meshheading:12858187-Callithrix,
pubmed-meshheading:12858187-Disease Models, Animal,
pubmed-meshheading:12858187-Disease Susceptibility,
pubmed-meshheading:12858187-Encephalitis, Herpes Simplex,
pubmed-meshheading:12858187-Female,
pubmed-meshheading:12858187-Genetic Vectors,
pubmed-meshheading:12858187-Herpesvirus 1, Human,
pubmed-meshheading:12858187-Kidney,
pubmed-meshheading:12858187-Liver,
pubmed-meshheading:12858187-Male,
pubmed-meshheading:12858187-Polymerase Chain Reaction,
pubmed-meshheading:12858187-Survival Rate
|
pubmed:year |
2003
|
pubmed:articleTitle |
Development of a novel non-human primate model for preclinical gene vector safety studies. Determining the effects of intracerebral HSV-1 inoculation in the common marmoset: a comparative study.
|
pubmed:affiliation |
Neurosurgical Service, Massachusetts General Hospital East, Harvard Medical School, Charlestown, MA, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|